Skip to main content
. 2024 Jun 29;12(7):1453. doi: 10.3390/biomedicines12071453
AKT Protein kinase B LUSC Lung squamous cell carcinoma
ALK Anaplastic lymphoma kinase MAPK Mitogen-activated protein kinase
AMPK AMP-activated protein kinase MDM2 Mouse double minute 2 homolog
AT1 Alveolar type 1 MDMX Mouse double minute X
AT2 Alveolar type 2 mRNA Messenger RNA
ATM Ataxia telangiectasia mutated mTOR Mammalian target of rapamycin
ATR Ataxia telangiectasia and Rad3-related protein NGS Next-generation sequencing
CDKN2A Cyclin-dependent kinase inhibitor 2A NSCLC Non-small-cell lung cancer
CTD C-terminal domain OD Oligomerization domain
ctDNA Circulating tumor DNA p53RE p53-response elements
DBD DNA-binding domain PARP Poly-ADP ribose polymerase
DLL3 Delta-like ligand 3 PD-1 Programmed cell death protein 1
DNA Deoxyribonucleic acid PD-L1 Programmed cell death 1 ligand 1
DNMT DNA methyltransferase PI3K Phosphatidylinositol 3-kinase
EGFR Epidermal growth factor receptor PRD Proline-rich domain
FLp53 Full-length p53 PTEN Phosphatase and tensin homolog
GOF Gain of function Rap1A Ras-associated protein 1A
HDAC Histone deacetylase Rb1 Retinoblastoma 1 protein
ICIs Immune checkpoint inhibitors RhoC Ras homolog family member C
JNK c-Jun N-terminal kinase SCLC Small-cell lung cancer
LC Lung cancer TAD Transactivation domain
LOF Loss of function YAP Yes-associated protein
LUAD Lung adenocarcinoma